NMTC
Neuroone Medical Technologies Corp
NASDAQ: NMTC · HEALTHCARE · MEDICAL DEVICES
$4.70
+0.00% today
Updated 2026-04-30
Market cap
$38.95M
P/E ratio
—
P/S ratio
3.32x
EPS (TTM)
$-1.08
Dividend yield
—
52W range
$3 – $7
Volume
0.2M
WallStSmart proprietary scores
17
out of 100
Grade: F
Strong Sell
Investment rating
5.3
Growth
C+7.0
Quality
B+2.0
Profitability
F6.7
Valuation
B5/9
Piotroski F-Score
Moderate
-8.1
Altman Z-Score
Distress
—
Industry rank
—
View all highly rated stocks (75+) →202 stocks currently score above 75
Price targets
Analyst target
$12.20
+159.57%
12-Month target
—
—
Intrinsic (DCF)
$5.95
Margin of safety
+86.22%
1 Strong Buy1 Buy0 Hold0 Sell0 Strong Sell
Price chart
X-Ray snapshot
Strengths
+ 86.22% below intrinsic value
+ Debt/equity 0.02x — low leverage
Risks
- Altman Z -8.06 — distress zone
- Thin margins at -58.30%
- Negative free cash flow $-3.16M
- Revenue declining -11.70% QoQ
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $171169.00 | $1.95M | $3.45M | $12.10M | $11.72M |
| Net income | $-10.00M | $-11.86M | $-12.32M | $-3.61M | $-1.44M |
| EPS | — | — | — | — | $-1.08 |
| Free cash flow | $-7.79M | $-13.27M | $-11.13M | $-3.22M | $-3.16M |
| Profit margin | -5,841.95% | -607.42% | -356.74% | -29.80% | -58.30% |
Peer comparison
Smart narrative
Neuroone Medical Technologies Corp trades at $4.70. Our Smart Value Score of 17/100 indicates the stock is weak. The company scores 5/9 on the Piotroski F-Score. With an Altman Z-Score of -8.06, it sits in the distress. TTM revenue stands at $11.72M. with profit margins at -58.30%. Our DCF model estimates intrinsic value at $5.95.
Frequently asked questions
What is Neuroone Medical Technologies Corp's stock price?
Neuroone Medical Technologies Corp (NMTC) trades at $4.70.
Is Neuroone Medical Technologies Corp overvalued?
Smart Value Score 17/100 (Grade F, Strong Sell). DCF value $5.95.
What is the price target of Neuroone Medical Technologies Corp (NMTC)?
The analyst target price is $12.20, representing +159.6% upside from the current price of $4.70.
What is the intrinsic value of Neuroone Medical Technologies Corp (NMTC)?
Based on our DCF model, intrinsic value is $5.95, a +86.2% margin of safety versus $4.70.
What is Neuroone Medical Technologies Corp's revenue?
TTM revenue is $11.72M.
Piotroski F-Score?
5/9 — moderate financial health.
Altman Z-Score?
-8.06 — distress.
Company info
SectorHEALTHCARE
IndustryMEDICAL DEVICES
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio3.32x
ROE-146.30%
Beta0.58
50D MA$4.56
200D MA$4.76
Shares out0.01B
Float0.01B
Short ratio—
Avg volume0.2M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—